| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Recursion Pharmaceuticals, Inc. (RXRX) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. RXRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.65M | $21.15M | - | |
| Dir | 4.52M | $14.38M | - | |
| CEO | 2.26M | $7.19M | - | |
| Dir | 1.24M | $3.95M | - | |
| Other | 1.11M | $3.53M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 26, 2023 | Borgeson Blake69 | Director | Sell | 20,054 | $10.63 | $213,143.94 | -0.3% | -2.4% | -29.0% | |
| Dec 15, 2023 | Virani Shafique70 | Chief Business Officer | Sale+OE | 18,000 | $9.60 | $172,800.00 | -11.6% | +11.1% | -28.4% | |
| Dec 14, 2023 | Dar Zavain | Director | Sell | 20,141 | $9.00 | $181,269.00 | -27.2% | +15.2% | -27.1% | |
| Dec 13, 2023 | Secora Michael74 | Chief Financial Officer | Sale+OE | 50,000 | $7.49 | $374,637.50 | -2.6% | +26.5% | -16.2% | |
| Dec 12, 2023 | Borgeson Blake69 | Director | Sell | 11,447 | $7.40 | $84,692.92 | -0.2% | +39.4% | +1.7% | |
| Dec 6, 2023 | Gibson Christopher70 | Chief Executive Officer | Sale+OE | 59,829 | $7.49 | $448,394.42 | -7.0% | +60.5% | -11.2% | |
| Nov 28, 2023 | Borgeson Blake69 | Director | Sell | 11,447 | $6.72 | $76,918.12 | -0.2% | +110.3% | -9.1% | |
| Nov 16, 2023 | Larson Tina Marriott73 | President And COO | Sale+OE | 3,000 | $6.76 | $20,279.70 | -0.7% | +63.7% | -7.4% | |
| Nov 15, 2023 | Virani Shafique70 | Chief Business Officer | Sale+OE | 18,000 | $6.51 | $117,180.00 | -11.4% | +36.4% | -3.8% | |
| Nov 15, 2023 | Secora Michael74 | Chief Financial Officer | Sale+OE | 50,000 | $6.82 | $340,928.64 | -1.8% | +36.4% | -3.8% |